Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Navkiran K Shokar"'
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Colorectal cancer (CRC) is the second leading cause of cancer deaths in the USA. Although a number of CRC screening tests have been established as being effective for CRC prevention and early detection, rates of CRC screening test
Externí odkaz:
https://doaj.org/article/600482760e744f05adda54fb82c3764b
Autor:
Nikit Venishetty, Jessica Calderon-Mora, Navkiran K. Shokar, Pracheta Matharasi, Luis Garza, Celina Beltran, Jennifer Molokwu
Publikováno v:
Cancer Treatment and Research Communications, Vol 37, Iss , Pp 100756- (2023)
Colorectal cancer (CRC) is a leading cause of cancer-related deaths in Hispanics in the US. Despite this, Hispanics are being screened for CRC at a much lower rate than their non-Hispanic white counterparts. Implementing mailed fecal immunochemical t
Externí odkaz:
https://doaj.org/article/7a9f2944bc2e4dc886d3eafceca32c53
Autor:
Stella Winters, Adam Alomari, Gurjeet Shokar, Charmaine Martin, Alok Dwivedi, Navkiran K. Shokar
Publikováno v:
Preventive Medicine Reports, Vol 24, Iss , Pp 101561- (2021)
Breast cancer is the commonest occurring cancer and the leading cause of cancer death among Hispanic women in the USA. Although their overall breast cancer incidence and mortality is lower, incidence rates are rising faster and mortality declines are
Externí odkaz:
https://doaj.org/article/c83d66cd435244c69e5c13aeb1f33075
Publikováno v:
Cancer. 129:1569-1578
Publikováno v:
BMJ Open, Vol 10, Iss 10 (2020)
Objective This study examines the geographical and socioeconomic factors associated with uptake of colorectal cancer (CRC) screening (colonoscopies or faecal immunochemical test (FIT) testing).Design Secondary data analysis.Setting The Against Colore
Externí odkaz:
https://doaj.org/article/ba568d96c451414d85e0abaaffeaf76e
Autor:
Navkiran K. Shokar MA, MD, MPH, Amy Doan BS, Jessica Calderon-Mora MPH, DrPH, Rajkumar Lakshmanaswamy PhD, Subramani Ramadevi PhD, Gurjeet S. Shokar MD, Jennifer Molokwu MD, MPH, Adam Alomari MPH, Alok Dwivedi PhD
Publikováno v:
Cancer Control, Vol 27 (2020)
Introduction : Hispanic women residing along the US-Mexico border have the highest cervical cancer incidence rates in the US. Genital human papillomavirus (HPV) is the major causative agent, but more information is needed about the prevalence and dis
Externí odkaz:
https://doaj.org/article/ebb2d44ce501444893731f373b69c70a
Autor:
Silvia Flores-Luevano, Navkiran K Shokar, Alok Kumar Dwivedi, Gurjeet S Shokar, Sandrine N Defeu
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 14 (2020)
Introduction: Fear has been described as potentially important in affecting breast cancer screening completion. Limited information is available on the prevalence and determinants of fear among Mexican American women. This study describes perceived b
Externí odkaz:
https://doaj.org/article/c313ea4a58024d6f9edc46664eaae668
Autor:
F. Benjamin Zhan, Yanyan Liu, Mei Yang, Nicole Kluz, Todd A. Olmstead, Jenny Spencer, Navkiran K. Shokar, Roxana L. Cruz, Michael P. Pignone
Publikováno v:
Preventing Chronic Disease. 20
Autor:
Jennifer J Salinas, Theresa Byrd, Charmaine Martin, Alok K Dwivedi, Adam Alomari, Rebekah Salaiz, Navkiran K Shokar
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 12 (2018)
Purpose: To determine the relationship between breast cancer screening knowledge and intent to receive a mammogram within 6 months in a sample of Mexican-origin women living in El Paso, Texas. Methods: A total of 489 uninsured Mexican-origin women we
Externí odkaz:
https://doaj.org/article/4172c250bbae45a3a7333bbf180138c3
Autor:
KoKo Aung, Bhaskar Thakur, Joseph Benitez, Sireesha Reddy, Navkiran K. Shokar, Joshua P. Torres, Debabrata Mukherjee, Pallavi Dubey, Alok Dwivedi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Scientific Reports
Scientific Reports
Several comorbidities have been shown to be associated with coronavirus disease 2019 (COVID-19) related severity and mortality. However, considerable variation in the prevalence estimates of comorbidities and their effects on COVID-19 morbidity and m